metformin has been researched along with Adenohypophyseal Diseases in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin (MET) is a diabetes drug that activates AMP-activated protein kinase (AMPK), and is suggested to have anticancer efficacy." | 1.48 | Metformin inhibits growth and prolactin secretion of pituitary prolactinoma cells and xenografts. ( Bao, X; Deng, K; Feng, M; Gao, J; Han, G; Lian, W; Liu, X; Liu, Y; Lv, X; Wang, R; Xing, B; Yao, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, J | 1 |
| Liu, Y | 1 |
| Han, G | 1 |
| Deng, K | 1 |
| Liu, X | 1 |
| Bao, X | 1 |
| Feng, M | 1 |
| Yao, Y | 1 |
| Lian, W | 1 |
| Xing, B | 1 |
| Lv, X | 1 |
| Wang, R | 1 |
| Mirouze, J | 1 |
| Jaffiol, C | 1 |
| Mary, P | 1 |
2 other studies available for metformin and Adenohypophyseal Diseases
| Article | Year |
|---|---|
Metformin inhibits growth and prolactin secretion of pituitary prolactinoma cells and xenografts.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Apoptosis; Bromocriptine; Cell Proliferation; Estroge | 2018 |
[Extragonadal endocrine manifestations of Klinefelter's disease].
Topics: Adrenal Gland Diseases; Adult; Antibodies; Autoantibodies; Blood Glucose; Diabetes Mellitus; Diazoxi | 1973 |